Biofrontera Inc. — Investor Relations & Filings
Filings indexed
350
across all filing types
Latest filing
2026-03-19
Annual Report
Country
US
United States of America
Listing
US
BFRI
Biofrontera Inc. is a biopharmaceutical company that commercializes a portfolio of pharmaceutical products for the treatment of dermatological conditions. The company specializes in photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used to treat actinic keratoses, a type of pre-cancerous skin lesion, and impetigo, a bacterial skin infection. Biofrontera focuses on establishing PDT as a standard of care in dermatology and utilizes a proprietary nanoemulsion technology to improve the stability and skin penetration of its formulations, potentially increasing clinical efficacy.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | |
| 8-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 32989302 | 10-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | ||
| 32986713 | 8-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | ||
| 32911294 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911293 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911292 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911288 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911287 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911284 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911281 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32899942 | 8-K - BIOFRONTERA INC. (0001858685) (Filer) | 2026-02-26 | English | ||
| 32100293 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 32100370 | 8-K Filing | 2026-02-09 | English | ||
| 32100337 | SCHEDULE 13G/A Filing | 2026-01-28 | English | ||
| 13442747 | 8-K | 2026-01-13 | English | ||
| 13442785 | 8-K | 2026-01-07 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Afexa Life Sciences Inc.
Researched, developed, and manufactured naturally derived O…
|
FXA | CA | Manufacturing |
|
AFT Pharmaceuticals Limited
Develops, licenses, and distributes pharmaceuticals across …
|
AFT | NZ | Manufacturing |
|
AFT PHARMACEUTICALS LIMITED
Develops and licenses healthcare products for pain manageme…
|
AFP | AU | Manufacturing |
|
AGENUS INC
A clinical-stage biotechnology company specializing in immu…
|
AGEN | US | Manufacturing |
|
AGIOS PHARMACEUTICALS, INC.
Biopharmaceutical company developing therapies for rare and…
|
AGIO | US | Manufacturing |
|
AHN-GOOK PHARMACEUTICAL Co., Ltd.
Develops and markets medicines, focusing on respiratory and…
|
001540 | KR | Manufacturing |
|
AIM Vaccine Co., Ltd.
Develops, manufactures, and commercializes established and …
|
6660 | HK | Manufacturing |
|
AION THERAPEUTIC INC.
Health and wellness company developing AI-driven bio-pharma…
|
AION | CA | Manufacturing |
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
Biofrontera Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35198/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35198 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35198 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35198 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35198}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biofrontera Inc. (id: 35198)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.